This technology provides a new semi-synthetic biological pharmaceutical manufacturing process to produce a high quality, low cost, stable supply of artemisinin, a key ingredient in pharmaceutical treatments for malaria. This can result in the saving of many lives in the impoverished areas most affected by the most virulent forms of malaria.